What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report

Monica M. Bertagnolli, Charles D. Blanke, Walter J. Curran, Douglas S. Hawkins, Robert S. Mannel, Peter J. O’Dwyer, Mitchell D. Schnall, Norman Wolmark

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

The US cancer cooperative groups (cooperative groups) were founded in the 1950s to establish a standing infrastructure to conduct multi-institutional cancer clinical trials. Initially funded almost entirely by the US National Cancer Institute (NCI), over the years, the research conducted by the Cooperative Groups has evolved to meet the demands of cancer clinical research, with a scope now encompassing trials to advance cancer treatment, cancer control, biomarker development and validation, and health services research, with a corresponding broadening of their funding sources. The cooperative groups are also a critical mechanism for educating the next generation of cancer clinical trialists from many different disciplines. This review outlines the overall mission, structure, and funding of the cooperative groups, beginning in 1955 when they were first established by the NCI, and describes the considerable progress against cancer achieved over the past decade.

Original languageEnglish (US)
Pages (from-to)5022-5029
Number of pages8
JournalCancer
Volume126
Issue number23
DOIs
StatePublished - Dec 1 2020

Keywords

  • NCI Community Oncology Research Program (NCORP)
  • NCI National Clinical Trials Network (NCTN)
  • National Cancer Institute (NCI)
  • cancer clinical trials
  • cooperative groups

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report'. Together they form a unique fingerprint.

Cite this